Conformation-X Therapeutics

Canton, United States

Conformation-X Therapeutics is an immune-oncology focused drug development company.

$3.6M raised

Apr 2024

Seed

Biotechnology Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Conformation-X Therapeutics

How much funding has Conformation-X Therapeutics raised?

Conformation-X Therapeutics has raised $3.6M in total funding. The most recent round was Seed. The last funding was announced in April 2024.

Where is Conformation-X Therapeutics headquartered?

Conformation-X Therapeutics is headquartered in Canton, United States.

What does Conformation-X Therapeutics do?

Conformation-X Therapeutics is an immune-oncology focused drug development company.

What stage is Conformation-X Therapeutics at?

Conformation-X Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 3, 2024.

MLA

"Conformation-X Therapeutics — Funding & Investors." VCBacked, April 3, 2024, https://www.vcbacked.co/company/conformation-x-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2024). Conformation-X Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/conformation-x-therapeutics

Wikipedia (cite web)

{{cite web |title=Conformation-X Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/conformation-x-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 3, 2024.